Right Ventricle Free Wall Longitudinal Strain in Cancer Patients Following Chemotherapy

Authors

  • Aussie Fitriani Ghaznawie Department of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar
  • Akhtar Fajar Muzakkir Department of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar
  • F. Fathlina a:1:{s:5:"en_US";s:88:"Department of Cardiology and Vascular Medicine Faculty of Medicine Hasanuddin University";}
  • Ali Aspar Mappahya Department of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar
  • Abdul Hakim Alkatiri Department of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar
  • Andi Alfian Zainuddin Department of Public Health and Community Medicine, Faculty of Medicine, Hasanuddin University, Makassar
  • Prihantono Prihantono Oncology Division, Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar

DOI:

https://doi.org/10.20956/nmsj.v8i1.26648

Abstract

Introduction: The survival rate of cancer patients was high due to chemotherapy, but it can cause cardiotoxicity and increase morbidity and mortality. Most studies on cancer therapy-related cardiac dysfunction (CTRCD) focus more on the left ventricle. This study assesses chemotherapy's effect on the right ventricle, namely the right ventricle free wall longitudinal strain (RVFWLS). Methods: This study is a prospective cohort conducted from January to December 2022 on thirty-four cancer patients undergoing chemotherapy at Dr Wahidin Sudirohusodo Hospital Makassar. The RVFWLS was assessed before and after chemotherapy using echocardiographic. Result: The RVFWLS value after one cycle chemotherapy decreased compared pre-chemotherapy (4.40±4.84; p=0.001). Conclusion: The effect of chemotherapy is a decrease the RVFWLS value after the first cycle of chemotherapy. It should be considered for echocardiographic evaluation, especially the RVFWLS value every cycle of chemotherapy.

Author Biographies

Aussie Fitriani Ghaznawie, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar

 

 

F. Fathlina, a:1:{s:5:"en_US";s:88:"Department of Cardiology and Vascular Medicine Faculty of Medicine Hasanuddin University";}

 

 

 

 

References

Tim Riskesdas (2019) ‘Laporan Nasional Riskesdas 2018’, Badan Penelitian dan Pengembangan Kesehatan, p. 198. Available at: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf.

World Heart Organization (2020) ‘Cancer Incident In The World’, WHO.

Amstrong GT, Oeffinger KC, Chen Y, Kawashima T, et al. Modifiable Risk Factors and Major Cardiac Event among Adult Survivors of Childhood Cancer. J Clin Oncol 2013;31:3673-3680

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, et al. Cancer Incidence and Mortality Patterns in Europe: Estimates for 40 Countries in 2012. Eur J Cancer 2013;49:1374-1403

Hamo CE, Bloom MW. Cancer and heart failure: Understanding the intersection. Cardiac Failure Review 2017;3(1):66-70

Tanindi, A. et al. (2011) ‘Assessment of right ventricular functions during cancer chemotherapy’, European Journal of Echocardiography, 12(11), pp. 834–840. doi: 10.1093/ejechocard/jer142.

Chang, W. T. et al. (2016) ‘The early predictive value of right ventricular strain in epirubicin-induced cardiotoxicity in patients with breast cancer’, Acta Cardiologica Sinica, 32(5), pp. 550–559. doi: 10.6515/ACS20151023A.

Xu, H. et al. (2021) ‘Assessment of subclinical deterioration of right ventricular function by three-dimensional speckle tracking echocardiography in breast cancer patients undergoing anthracycline-based chemotherapy’, International Journal of General Medicine, 14, pp. 885–893. doi: 10.2147/IJGM.S300257.

Cherata, D. A. et al. (2019) ‘Longitudinal strain analysis allows the identification of subclinical deterioration of right ventricular function in patients with cancer therapy-related left ventricular dysfunction’, Discoveries, 7(2), p. e94. doi: 10.15190/d.2019.7.

Lenneman, C. G. and Sawyer, D. B. (2016) ‘Cardio-oncology: An update on cardiotoxicity of cancer-related treatment’, Circulation Research, 118(6), pp. 1008–1020. doi: 10.1161/CIRCRESAHA.115.303633.

Armenian, S. H., Lacchetti, C. and Lenihan, D. (2017) ‘Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline summary’, Journal of Oncology Practice, 13(4), pp. 270–275. doi: 10.1200/JOP.2016.018770.

Perez, I. E. et al. (2019) ‘Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician’, Clinical Medicine Insights: Cardiology, 13. doi: 10.1177/1179546819866445.

Planek, M. I. C. et al. (2020) ‘Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction’, Cardio-Oncology, 6(1), pp. 4–11. doi: 10.1186/s40959-020-00066-8.

Kaklamani, V. G. and Gradishar, W. J. (2003) ‘Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?’, Clinical Breast Cancer, 4(SUPPL. 1), pp. 26–33. doi: 10.3816/CBC.2003.s.012.

Downloads

Published

2023-08-02

How to Cite

Ghaznawie, A. F., Muzakkir, A. F., Fathlina, F., Mappahya, A. A., Alkatiri, A. H., Zainuddin, A. A., & Prihantono, P. (2023). Right Ventricle Free Wall Longitudinal Strain in Cancer Patients Following Chemotherapy. Nusantara Medical Science Journal, 8(1), 38–46. https://doi.org/10.20956/nmsj.v8i1.26648

Issue

Volume 8 Issue 1, January - June 2023

Section

Articles

License

Copyright (c) 2023 Nusantara Medical Science Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.